Assessment of Disease Burden in Hairy Cell Leukemia
ConditionHairy Cell Leukemia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
About this trial
Drug-free, single-center, prospective observational pilot study in hairy Cell Leukemia patients
Eligibility criteria
Qualifiers
newly diagnosed and candidates for first-line cytoreductive treatment with analogues purines or
in relapse after a previous line of treatment, with indication for rescue therapy (repetition of a purine analogue; use of targeted or innovative drugs), except splenectomy or
in CR for at least 5 years after a first line of treatment, in the absence of clinical alterations indicative of a state of hematological relapse, or in any case in the absence of an indication for a new line of cytoreductive therapy (time-to-next treatment exceeding 5 years).
Age ≥ 18 years at enrollment
Disqualifiers
None
Trial design
Treatments tested in this trial
- Peripheral and BM blood sample
Treatment groups
45 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov